Exploring Mitochondrial Dysfunction in Diseases: Insights from the University of Strathclyde
Listen to Dr Louise Young, a research fellow at the University of Strathclyde, as she discusses her groundbreaking research into mitochondrial dysfunction and its impact on various diseases.
Her lab focuses on neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as cancer and other conditions. Dr Young explains how her team collaborates with chemists to discover novel drug compounds that target mitochondrial dysfunction.
In her research, Dr Young utilises Promega assays, including CellTiter-Glo®, Annexin V, and ROS-Glo™, to measure mitochondrial health. She highlights the benefits of using ROS-Glo™, a homogeneous assay that eliminates the need for washing steps, making it more efficient and accurate for her research.
Watch the full video to learn about the promising results of this research and the next steps in finding potential therapies for diseases related to mitochondrial dysfunction.
For more information, visit Promega UK's blog page at https://www.promega.co.uk/c/uk-blog/a...